First Cancer Patients in Taiwan Treated with Varian HyperArc High-Definition Radiotherapy
PALO ALTO, Calif., Jan. 17, 2019 -- (Healthcare Sales & Marketing Network) -- Varian (NYSE: VAR) announced 10 patients at the Chi Mei Medical Center with brain lesions became the first patients in Taiwan to be treated using the company's HyperArc High De... Devices, Oncology Varian Medical Systems, HyperArc, High Definition, Radiotherapy
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news
More News: Brain | Brain Cancers | Cancer | Cancer & Oncology | Marketing | Neurology | Pharmaceuticals | Taiwan Health